<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04346485</url>
  </required_header>
  <id_info>
    <org_study_id>Sechenov-RIRS-20</org_study_id>
    <nct_id>NCT04346485</nct_id>
  </id_info>
  <brief_title>Comparison of SP TFL and Ho:YAG for RIRS Using 145 µm and 200 µm Fibers</brief_title>
  <official_title>Prospective Randomized Comparison of SP TFL and Ho:YAG for RIRS Using 145 µm and 200 µm Fibers for the Management of Lower Pole Kidney Stones: Single-center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>I.M. Sechenov First Moscow State Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>I.M. Sechenov First Moscow State Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The authors hypothesize that the RIRS using 150-microm Tm-fiber laser is superior than fiber
      with larger diameters, as 200-microm Tm-fiber laser or 200-microm holmium fiber laser, in
      such points as follows:

        -  decreasing surgery time and laser-on time due to possibility of 4.3 fold ablation
           efficacy increase, which has been shown by Andreeva et al.;

        -  increasing the flexible ureteroscope tip deflection lower pole stones availability;

        -  decreased risk of complications and a better irrigation and visualization due to better
           irrigation with smaller fiber;

        -  increasing of lithotripsy efficacy and laser beam density by lowering of beam focal spot
           due to using of lesser fiber diameter
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RIRS will be performed with SP TFL or Ho:YAG (100 W). The procedure is performed under
      general anesthesia with the patient in the dorsal lithotomy position. The bladder is entered
      either with a cystoscope or a semi-rigid ureterorenoscope. Guidewires (0.035&quot;) will be used
      to facilitate access (under fluoroscopic guidance). After access sheath (12/14) will be
      placed up to the kidney pelvis. Through the access sheath ureteroscope will be introduced.
      For nephrolithotripsy 145 mcm and 200 mcm fibers will be used. Large fragments could be
      extracted with nitinol basket. After the surgery ureteral stent (7 Fr.) will be placed inside
      the ureter for 10 to 14 days.

      A 10 Fr urethral catheter can be placed in the bladder for the drainage of the bladder during
      the operation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 13, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 13, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Laser-on time</measure>
    <time_frame>during surgery</time_frame>
    <description>Time of laser emission during surgery, seconds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>during surgery and 6 months after surgery</time_frame>
    <description>Complications according to Clavien-Dindo classification (higher score means more severe complication)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>during surgery</time_frame>
    <description>Surgery duration, minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin drop</measure>
    <time_frame>1 day after surgery</time_frame>
    <description>Change of hemoglobin level 1 day after surgery comparing to pre-operative value, g/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catheter stay</measure>
    <time_frame>1 week</time_frame>
    <description>duration of catheterisation, days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalization length</measure>
    <time_frame>1 week</time_frame>
    <description>Duration of hospital stay after surgery, days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation exposure</measure>
    <time_frame>during surgery</time_frame>
    <description>Duration of X-ray exposure, sec.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation exposure</measure>
    <time_frame>during surgery</time_frame>
    <description>Effective dose, mSv</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stone-free rate</measure>
    <time_frame>3 month</time_frame>
    <description>Percentage of patients with absence of stones larger 3 mm in maximum size on follow-up CT</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Kidney Stone</condition>
  <condition>Nephrolithiasis</condition>
  <condition>Urolithiasis</condition>
  <arm_group>
    <arm_group_label>SP TFL RIRS with 145 mcm fiber</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Superpulse thulium fiber laser RIRS with 145 mcm laser fiber</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SP TFL RIRS with 200 mcm fiber</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Superpulse thulium fiber laser RIRS with 200 mcm laser fiber</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ho:YAG RIRS with 200 mcm fiber</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ho:YAG laser RIRS with 200 mcm laser fiber</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SP TFL RIRS with 145 mcm fiber</intervention_name>
    <description>retrograde intrarenal surgery</description>
    <arm_group_label>SP TFL RIRS with 145 mcm fiber</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SP TFL RIRS with 200 mcm fiber</intervention_name>
    <description>retrograde intrarenal surgery</description>
    <arm_group_label>SP TFL RIRS with 200 mcm fiber</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ho:YAG RIRS with 200 mcm fiber</intervention_name>
    <description>retrograde intrarenal surgery</description>
    <arm_group_label>Ho:YAG RIRS with 200 mcm fiber</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and Females &gt; 18 y.o.;

          -  Radiologically confirmed (CT) kidney stone;

          -  Stone size from 10 to 20 mm.

        Exclusion Criteria:

        • Multiple (more than 3) kidney stones &gt; 5 mm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute for Urology and Reproductive Health, Sechenov University.</name>
      <address>
        <city>Moscow</city>
        <zip>119991</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dmitry Enikeev, MD</last_name>
      <phone>+7 925 517 79 26</phone>
      <email>enikeev-dv@1msmu.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 12, 2020</study_first_submitted>
  <study_first_submitted_qc>April 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>April 10, 2020</last_update_submitted>
  <last_update_submitted_qc>April 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>I.M. Sechenov First Moscow State Medical University</investigator_affiliation>
    <investigator_full_name>Dmitry Enikeev, MD, PhD</investigator_full_name>
    <investigator_title>Deputy director for research</investigator_title>
  </responsible_party>
  <keyword>RIRS</keyword>
  <keyword>holmium laser</keyword>
  <keyword>superpulse thulium laser</keyword>
  <keyword>kidney stone disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

